Healthcare provider profile · identity verified

Joseph J. Behal, MD

Family Practice · TAVARES, FL · NPI 1518945377

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Quetiapine Fumarate	Quetiapine Fumarate	324	52
Atorvastatin Calcium	Atorvastatin Calcium	250	53
Amlodipine Besylate	Amlodipine Besylate	239	52
Lisinopril	Lisinopril	172	54
Memantine Hcl	Memantine Hcl	171	27
Donepezil Hcl	Donepezil Hcl	156	33
Levothyroxine Sodium	Levothyroxine Sodium	151	36
Gabapentin	Gabapentin	145	22
Omeprazole	Omeprazole	140	28
Rosuvastatin Calcium	Rosuvastatin Calcium	139	20
Metoprolol Tartrate	Metoprolol Tartrate	136	21
Eliquis	Apixaban	130	23
Metoprolol Succinate	Metoprolol Succinate	126	30
Metformin Hcl	Metformin Hcl	124	29
Furosemide	Furosemide	105	29
Lorazepam	Lorazepam	100	18
Tamsulosin Hcl	Tamsulosin Hcl	91	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	suppressed
Risperidone	Risperidone	89	11
Pantoprazole Sodium	Pantoprazole Sodium	87	23
Carvedilol	Carvedilol	86	18
Divalproex Sodium	Divalproex Sodium	83	suppressed
Levetiracetam	Levetiracetam	79	14
Famotidine	Famotidine	77	18
Losartan Potassium	Losartan Potassium	74	20
Trazodone Hcl	Trazodone Hcl	74	12
Mirtazapine	Mirtazapine	67	13
Divalproex Sodium Er	Divalproex Sodium	61	suppressed
Potassium Chloride	Potassium Chloride	61	19
Olanzapine	Olanzapine	59	suppressed
Sertraline Hcl	Sertraline Hcl	50	12
Simvastatin	Simvastatin	50	11
Digoxin	Digoxin	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Estradiol	Estradiol	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Paliperidone Er	Paliperidone	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	12
Montelukast Sodium	Montelukast Sodium	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	25
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Azithromycin	Azithromycin	29	15
Albuterol Sulfate Hfa	Albuterol Sulfate	28	suppressed
Sucralfate	Sucralfate	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Atenolol	Atenolol	25	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Lactulose	Lactulose	23	suppressed
Allopurinol	Allopurinol	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Torsemide	Torsemide	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Prednisone	Prednisone	16	suppressed
Temazepam	Temazepam	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Niacin Er	Niacin	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Clozapine	Clozapine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Loxapine	Loxapine Succinate	12	suppressed
Methimazole	Methimazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Primidone	Primidone	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Zenpep	Lipase/Protease/Amylase	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Finasteride	Finasteride	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error